Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Merck Sharp & Dohme LLC
Gilead Sciences
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
City of Hope Medical Center
Hospital of Stomatology, Wuhan University
GlaxoSmithKline
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Stanford University
Medical University of Vienna
Merck Sharp & Dohme LLC
University of Kentucky
Bristol-Myers Squibb
Wake Forest University Health Sciences
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Radiation Therapy Oncology Group
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Emory University
University of Kansas Medical Center
University of Miami
University of Michigan Rogel Cancer Center
Sanofi
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Radiation Therapy Oncology Group
Vanderbilt-Ingram Cancer Center